{"title":"放射碘难治性分化甲状腺癌中lenvatinib治疗相关不良事件的处理","authors":"M. Cabanillas, S. Takahashi","doi":"10.17650/2222-1468-2019-9-4-49-61","DOIUrl":null,"url":null,"abstract":"<jats:p>.</jats:p>","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":"{\"title\":\"Managing the adverse events associated with lenvatinib therapy in radioiodine-refractory differentiated thyroid cancer\",\"authors\":\"M. Cabanillas, S. Takahashi\",\"doi\":\"10.17650/2222-1468-2019-9-4-49-61\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<jats:p>.</jats:p>\",\"PeriodicalId\":36598,\"journal\":{\"name\":\"Opuholi Golovy i Sei\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-02-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Opuholi Golovy i Sei\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17650/2222-1468-2019-9-4-49-61\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Opuholi Golovy i Sei","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/2222-1468-2019-9-4-49-61","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
